OR5D14 Inhibitors
OR5D14 inhibitors are a class of chemical compounds that target the OR5D14 receptor, a member of the olfactory receptor family, part of the G-protein-coupled receptor (GPCR) superfamily. OR5D14, like other olfactory receptors, is primarily involved in the detection of volatile molecules, which allows for the sense of smell. Structurally, these receptors possess the characteristic seven transmembrane domains found in GPCRs, which facilitate signal transduction from external ligands to intracellular pathways via G-proteins. Inhibitors of OR5D14 are typically designed to interfere with the receptor's ability to bind specific odorant molecules, thereby modulating the signaling cascade that would otherwise result in the perception of certain smells. By inhibiting the OR5D14 receptor, these compounds can block or alter olfactory signaling associated with specific ligand-receptor interactions. The exact molecular mechanisms can involve competitive inhibition, where the inhibitor competes with the natural ligand for the active site on the receptor, or allosteric inhibition, where binding occurs at a secondary site that changes the receptor's conformation.
The structural diversity of OR5D14 inhibitors often reflects the variety of molecules that these receptors are naturally designed to detect. The design of these inhibitors frequently leverages the receptor's unique binding pocket, which is fine-tuned to recognize specific structural motifs in odorant molecules. This specificity is crucial for creating compounds that selectively inhibit OR5D14 without affecting other closely related olfactory receptors. In addition, computational methods such as molecular docking and virtual screening are often employed in the design of OR5D14 inhibitors to predict binding affinities and guide the chemical synthesis of potent inhibitors. Structural elucidation of OR5D14, including detailed analysis of its active and inactive states, provides valuable insights into how these inhibitors interact at the molecular level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
This toxin is a known inhibitor of RNA polymerase II, which is critical for mRNA synthesis. By inhibiting this enzyme, α-Amanitin would directly prevent the transcription of the OR5D14 gene, thereby downregulating its expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to the DNA template at the transcription initiation complex, obstructing RNA polymerase movement and thereby directly halting the transcription of genes including OR5D14, leading to a decrease in its mRNA and protein levels. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This chemical agent inhibits DNA methyltransferase, causing DNA demethylation. Demethylation of promoter regions can often silence genes, but it can also reactivate silenced genes depending on the genomic context, potentially reducing the expression of OR5D14 if it leads to a less permissive chromatin state for transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A leads to hyperacetylation of histones, which can either enhance or suppress gene expression. In the case of OR5D14, if hyperacetylation results in a closed chromatin conformation at the OR5D14 locus, this would lead to a decrease in the gene's expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
This agent preferentially binds to G-C rich sequences in DNA, blocking the binding of transcription factors necessary for the initiation of transcription, which would result in the downregulation of OR5D14 expression if its promoter contains such sequences. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine intercalates into DNA, which can inhibit DNA replication and RNA synthesis. This intercalation could obstruct the transcription machinery from accessing the DNA, leading to a decrease in OR5D14 expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB is a potent inhibitor of RNA polymerase II phosphorylation, which is essential for the initiation and elongation phases of transcription. Inhibition by DRB could lead to the suppression of OR5D14 gene transcription and a consequent decrease in its expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to the FKBP12 protein and together they inhibit mTORC1, a key regulator of protein synthesis and cell growth. This inhibition could lead to a broad reduction in protein synthesis, including the downregulation of OR5D14 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This compound is a specific inhibitor of PI3K, a kinase involved in the activation of AKT, leading to the promotion of protein synthesis and cell survival. By inhibiting PI3K, LY 294002 can lead to reduced phosphorylation and activation of AKT, ultimately resulting in the decreased synthesis of proteins like OR5D14. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a selective inhibitor of MEK, which is part of the MAPK/ERK pathway—a pathway that can enhance gene expression. By inhibiting MEK, PD98059 can reduce the expression of downstream genes, potentially including OR5D14. | ||||||